申请人:HIMMELSBACH Frank
公开号:US20120322784A1
公开(公告)日:2012-12-20
The present invention relates to compounds of formula I,
wherein the groups R
1
, L
P
, L
Q
, X
1
, X
2
, X
3
, Ar and n are as defined in the application, which have valuable pharmacological properties, and in particular bind to the GPR119 receptor and modulate its activity.
本发明涉及公式I的化合物,
其中R
1
,LP,LQ,X
1
,X
2
,X
3
,Ar和n的定义如申请中所述,具有有价值的药理特性,特别是结合GPR119受体并调节其活性。